Vagantin en es it fr

Vagantin Brand names, Vagantin Analogs

Vagantin Brand Names Mixture

  • No information avaliable

Vagantin Chemical_Formula

C21H26NO3

Vagantin RX_link

No information avaliable

Vagantin fda sheet

Vagantin msds (material safety sheet)

Vagantin Synthesis Reference

No information avaliable

Vagantin Molecular Weight

340.436 g/mol

Vagantin Melting Point

No information avaliable

Vagantin H2O Solubility

No information avaliable

Vagantin State

Solid

Vagantin LogP

No information avaliable

Vagantin Dosage Forms

Tablet (50 mg)

Vagantin Indication

For the treatment of peptic ulcer disease, irritable bowel syndrome, pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, and reflex neurogenic bladder in children.

Vagantin Pharmacology

Methantheline is a synthetic quarternary ammonium antimuscarinic used to relieve cramps or spasms of the stomach, intestines, and bladder. It can be used together with antacids or other medicines, such as H2-receptor antagonists, in the treatment of peptic ulcer. Methantheline inhibits muscarinic actions at postganglionic parasympathetic neuroeffector sites.

Vagantin Absorption

Rapidly absorbed.

Vagantin side effects and Toxicity

Symptoms of overdose: blurred vision (continuing) or changes in near vision, clumsiness or unsteadiness, confusion, convulsions, difficulty in breathing, muscle weakness (severe), or tiredness (severe), dizziness, drowsiness (severe), dryness of mouth, nose, or throat (severe), fast heartbeat, fever, hallucinations, slurred speech, unusual excitement, nervousness, restlessness, or irritability, unusual warmth, dryness, and flushing of skin.

Vagantin Patient Information

No information avaliable

Vagantin Organisms Affected

Humans and other mammals